05 April 2023
Join Stephanie Morris, Director Innovation and Translation for the Adelaide Intermediary Program as she hosts MTPConnect’s next SA Insights Series in April featuring the South Australian immunoGENomics Cancer Institute (SAiGENCI).
SAiGENCI is an independent cancer-focused medical research institute located in South Australia; focusing on cancer research and clinical trials, which will include new cutting-edge technologies in immunotherapies and genomics.
Stephanie will host a fire-side chat with Professor Chris Sweeney, SAiGENCI's inaugural Director.
Professor Sweeney is a Medical Oncologist, formerly with the Dana-Farber Cancer Institute in Boston, Massachusetts, and Professor of Medicine at Harvard Medical School. Professor Sweeney received his medical degree from the University of Adelaide in 1992 and completed an internship at the Royal Adelaide Hospital. His primary research interest is drug discovery and development. His academic focus is the management of genitourinary malignancies, with a focus on prostate and testicular cancer.
Join us on Thursday, April 27 2023, from 5 - 7pm ACST, at G030 Lecture Theatre, Adelaide Health and Medical Sciences, The University of Adelaide and take the opportunity to network over drinks and nibbles afterwards.
The Adelaide Intermediary Program is connecting and empowering SA's health and medical innovation ecosystem, and working in in partnership with Adelaide Biomed City and the Government of South Australia!
Who should attend:
Researchers, C-suite professionals in the HMI sector, investors, and entrepreneurs, clinicians, entrepreneurs, founders, MTP industry professionals, commercialisation professionals, members of the Adelaide ecosystem.